Published Online First: 14 June 2006. doi:10.1136/jcp.2005.034447
Journal of Clinical Pathology 2007;60:397-404
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays
Katrine L Henriksen1,
Birgitte B Rasmussen2,
Anne E Lykkesfeldt1,
Susann Møller3,
Bent Ejlertsen4,
Henning T Mouridsen3,4
1 Department of Tumor Endocrinology, Institute of Cancer Biology, Danish Cancer Society, Copenhagen Ø, Denmark
2 Department of Pathology, Roskilde County Hospital, Roskilde, Denmark
3 Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen Ø, Denmark
4 Department of Oncology, Rigshospitalet, Copenhagen Ø, Denmark
Correspondence to:
Dr B B Rasmussen
Department of Pathology, Nordsjaellands Hospital, Hilleroed, Helsevej 2, DK-3400 Hilleroed, Denmark; bbr{at}noh.regionh.dk
Aim: To assess whether immunohistochemically stained tissue microarrays (TMA) of 2 mm cores from paraffin embedded tumour tissue may replace whole sections in semi-quantitative evaluation of selected potential markers for endocrine treatment.
Methods: Whole sections and 2 mm cores on TMA were used for immunohistochemical staining of potential markers for endocrine treatment. The Allred scoring system was used for the markers with nuclear localisation: the oestrogen receptor, the progesterone receptor, p27 and the oestrogen receptor co-regulator amplified in breast cancer 1 (AIB1). The Allred scoring system was also used for the non-nuclear markers Bcl-2, pS2 and cyclooxygenase 2 (COX-2); the membrane receptors HER-2, insulin-like growth factor I receptor (IGF-IR) and epidermal growth factor receptor were quantified according to the guidelines for the Herceptest.
Results: The data and statistical analyses showed that the semi-quantitative evaluation of oestrogen receptor, progesterone receptor, AIB1, COX-2, HER-2 and IGF-IR on TMA blocks was comparable with analysis on whole sections.
Conclusions: This study shows that semi-quantitative scoring of 2 mm cores on TMA is feasible for several potential markers for endocrine therapy. Considering the small size of many breast tumours, the speed and cost-effectiveness of immunohistochemistry on TMA compared with whole sections, and the importance of the expression level of the proteins, semi-quantitative scoring on TMA has great potential in both retrospective and prospective studies aiming at improving the prediction of response to endocrine treatment.
Abbreviations: AIB1, oestrogen receptor co-regulator amplified in breast cancer 1; COX-2, cyclooxygenase 2; EGFR, epidermal growth factor receptor; IHC, immunohistochemistry; IGF-IR, insulin-like growth factor I receptor; TMA, tissue microarray
This article has been cited by other articles:

|
 |

|
 |
 
C B Nunes, R M Rocha, J S Reis-Filho, M B Lambros, G F S Rocha, F S F Sanches, F N Oliveira, and H Gobbi
Comparative analysis of six different antibodies against Her2 including the novel rabbit monoclonal antibody (SP3) and chromogenic in situ hybridisation in breast carcinomas
J. Clin. Pathol.,
August 1, 2008;
61(8):
934 - 938.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Terms and conditions relating to subscriptions purchased online ¦ Website terms and conditions ¦ Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.